SITC Resource Library

35th Anniversary Annual Meeting: Session 404: Next Generation Immunotherapy Combinations: Navigating FDA, Clinical Trial Design, Diagnostics and Novel Biomarkers 

10-20-2020 18:39

The Society for Immunotherapy of Cancer (SITC) hosted “Session 404: Next Generation Immunotherapy Combinations: Navigating FDA, Clinical Trial Design, Diagnostics and Novel Biomarkers” during the 35th Anniversary Annual Meeting & Pre-Conference Programs on November 14, 2020. Available here are the presentation slides and video from the session, as permitted by presenters.

 

35th Anniversary Annual Meeting Organizers

  • Helen E. Heslop, MD – Baylor College of Medicine
  • Brianna W. Hoffner, MSN, ANP-BC, AOCNP – Harborside
  • Miriam Merad, MD, PhD – Icahn School of Medicine at Mount Sinai
  • Padmanee Sharma, MD, PhD – The University of Texas MD Anderson Cancer Center
  • Jedd D. Wolchok, MD, PhD – Memorial Sloan Kettering Cancer Center

 

Session Co-Chairs

  • Emily Hopewell, PhD, MT – Indiana University
  • Ke Liu, MD, PhD – Food and Drug Administration (FDA)
  • Jason Luke, MD, FACP – UPMC
  • Marc Theoret, MD – Food and Drug Administration (FDA), CDER, OHOP

 

To view the entire program schedule (including presenter permission to post) please click here.

Statistics
0 Favorited
55 Views
7 Files
0 Shares
31 Downloads
Attachment(s)
mp4 file
FDA Overview" - Recorded Video   102.82 MB   1 version
Uploaded - 12-18-2020
Meeting: SITC 35th Anniversary Annual Meeting; Session 404: Next Generation Immunotherapy Combinations: Navigating FDA, Clinical Trial Design, Diagnostics and Novel Biomarkers; Presenter: Adnan A. Jaigirdar, MD, FACS – Food and Drug Administration; Date: November 14, 2020
pdf file
FDA Overview" - Presentation   1.47 MB   1 version
Uploaded - 12-18-2020
Meeting: SITC 35th Anniversary Annual Meeting; Session 404: Next Generation Immunotherapy Combinations: Navigating FDA, Clinical Trial Design, Diagnostics and Novel Biomarkers; Presenter: Adnan A. Jaigirdar, MD, FACS – Food and Drug Administration; Date: November 14, 2020
mp4 file
"FDA Perspective on Areas of Research Needed in Advancing...   72.60 MB   1 version
Uploaded - 12-18-2020
Meeting: SITC 35th Anniversary Annual Meeting; Session 404: Next Generation Immunotherapy Combinations: Navigating FDA, Clinical Trial Design, Diagnostics and Novel Biomarkers; Presenter: Nicole Drezner, MD – Food and Drug Administration; Date: November 14, 2020
pdf file
"FDA Perspective on Areas of Research Needed in Advancing...   718 KB   1 version
Uploaded - 12-18-2020
Meeting: SITC 35th Anniversary Annual Meeting; Session 404: Next Generation Immunotherapy Combinations: Navigating FDA, Clinical Trial Design, Diagnostics and Novel Biomarkers; Presenter: Nicole Drezner, MD – Food and Drug Administration; Date: November 14, 2020
pdf file
science and logistics for investigators" - Presentation   5.07 MB   1 version
Uploaded - 12-18-2020
Meeting: SITC 35th Anniversary Annual Meeting; Session 404: Next Generation Immunotherapy Combinations: Navigating FDA, Clinical Trial Design, Diagnostics and Novel Biomarkers; Presenter: Cassian Yee, MD – The University of Texas MD Anderson Cancer Center; Date: November 14, 2020
mp4 file
"Improving patient selection in cellular therapy studies ...   84.92 MB   1 version
Uploaded - 12-18-2020
Meeting: SITC 35th Anniversary Annual Meeting; Session 404: Next Generation Immunotherapy Combinations: Navigating FDA, Clinical Trial Design, Diagnostics and Novel Biomarkers; Presenter: Rodabe N. Amaria, MD – The University of Texas MD Anderson Cancer Center; Date: November 14, 2020
pdf file
"Improving patient selection in cellular therapy studies ...   4.80 MB   1 version
Uploaded - 12-18-2020
Meeting: SITC 35th Anniversary Annual Meeting; Session 404: Next Generation Immunotherapy Combinations: Navigating FDA, Clinical Trial Design, Diagnostics and Novel Biomarkers; Presenter: Rodabe N. Amaria, MD – The University of Texas MD Anderson Cancer Center; Date: November 14, 2020

Related Entries and Links

No Related Resource entered.